Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
High Sierra Technologies (OTCPK:HSTI) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
High Sierra Technologies Equity-to-Asset Related Terms
High Sierra Technologies Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSTI vs HYEX, APUS, INIS: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, High Sierra Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
High Sierra Technologies Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, High Sierra Technologies's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where High Sierra Technologies's Equity-to-Asset falls into.
High Sierra Technologies Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
High Sierra Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
High Sierra Technologies (HSTI) has a Equity-to-Asset of -103.64 as of Sep. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on High Sierra Technologies and its competitors.
Is High Sierra Technologies' Equity-to-Asset too high?
High Sierra Technologies' current Equity-to-Asset is -103.64. Overall, High Sierra Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does High Sierra Technologies' Equity-to-Asset compare to HYEX and APUS?
High Sierra Technologies' Equity-to-Asset of -103.64 can be compared against companies in the Drug Manufacturers industry. The industry median Equity-to-Asset is 0.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on High Sierra Technologies and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. High Sierra Technologies's current Equity-to-Asset is -103.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is High Sierra Technologies stock overvalued right now?
High Sierra Technologies (HSTI) has a current Equity-to-Asset of -103.64. The current Equity-to-Asset is -103.64. High Sierra Technologies' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For High Sierra Technologies (HSTI), the current Equity-to-Asset is -103.64 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
High Sierra Technologies Inc is a start-up that develops and expands its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry. The company owns two provisional patent applications for producing new and novel cannabis products including low odor cannabis for smoking or as the starting materials for producing low odor cannabis products or flavored cannabis products.
18GF Score
Get the complete analysis for HSTI
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTI has been successfully added to your 
